Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 13 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Glioblastoma 2 Refractory Solid Tumors 1 Recurrence 1 Prostatic Neoplasms 1 Pediatric Solid Tumors 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Liver Diseases 1 Gliosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Advanced Cancers 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

vandetanib 2 veliparib 1 pralsetinib 1 ponatinib 1 lutetium Lu 177 dotatate 1 cabozantinib 1 Temozolomide 1 Sorafenib 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Medullary × Sorafenib × Clear all

NCT01736878 2013-05-17

SUMMIT

Eanm Research Ltd

Phase 2 Withdrawn

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡